Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 24,116 | 21,083 | 18,241 | 12,329 | 2,295 |
| Cost of Goods | 1,224 | 1,167 | 1,152 | 917 | 278 |
| Gross Profit | 22,892 | 19,916 | 17,089 | 11,412 | 2,017 |
| Operating Expenses | 32,348 | 33,679 | 29,459 | 31,212 | 37,395 |
| Operating Income | -9,232 | -13,596 | -12,218 | -18,883 | -35,100 |
| Interest Expense | 4,183 | 3,751 | 3,564 | 3,761 | 2,063 |
| Other Income | -7 | -111 | 77 | -10 | -12 |
| Pre-tax Income | -13,422 | -17,458 | -15,705 | -22,654 | -37,175 |
| Net Income Continuous | -13,422 | -17,458 | -15,705 | -22,654 | -37,175 |
| Net Income | $-13,422 | $-17,458 | $-15,705 | $-22,654 | $-37,175 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.13 | -0.21 | -0.37 |
| EPS Basic Continuous Ops | -0.10 | -0.10 | -0.13 | -0.21 | -0.37 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.13 | -0.21 | -0.37 |
| EPS Diluted Continuous Ops | -0.10 | -0.10 | -0.13 | -0.21 | -0.37 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.14 | -0.13 | -0.21 | -0.37 |
| EBITDA(a) | $-8,712 | $-13,064 | $-11,686 | $-18,313 | $-34,783 |